B7-H3 antibody-drug conjugate cuts death risk 54% in relapsed small-cell lung cancer
Relapsed small-cell lung cancer has long been one of the most difficult malignancies to treat once platinum-based chemotherapy fails, with ...
Relapsed small-cell lung cancer has long been one of the most difficult malignancies to treat once platinum-based chemotherapy fails, with ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine